Zhejiang Shenghua Biok Biology Co Ltd (600226) - Net Assets
Based on the latest financial reports, Zhejiang Shenghua Biok Biology Co Ltd (600226) has net assets worth CN¥3.61 Billion CNY (≈ $528.79 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.85 Billion ≈ $710.22 Million USD) and total liabilities (CN¥1.24 Billion ≈ $181.42 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Zhejiang Shenghua Biok Biology Co Ltd assets under control for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥3.61 Billion |
| % of Total Assets | 74.46% |
| Annual Growth Rate | 16.61% |
| 5-Year Change | 29.93% |
| 10-Year Change | 140.63% |
| Growth Volatility | 82.42 |
Zhejiang Shenghua Biok Biology Co Ltd - Net Assets Trend (1997–2024)
This chart illustrates how Zhejiang Shenghua Biok Biology Co Ltd's net assets have evolved over time, based on quarterly financial data. Check 600226 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Zhejiang Shenghua Biok Biology Co Ltd (1997–2024)
The table below shows the annual net assets of Zhejiang Shenghua Biok Biology Co Ltd from 1997 to 2024. For live valuation and market cap data, see market cap of Zhejiang Shenghua Biok Biology Co Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥3.42 Billion ≈ $499.76 Million |
-2.10% |
| 2023-12-31 | CN¥3.49 Billion ≈ $510.49 Million |
+12.96% |
| 2022-12-31 | CN¥3.09 Billion ≈ $451.92 Million |
+16.27% |
| 2021-12-31 | CN¥2.66 Billion ≈ $388.68 Million |
+1.05% |
| 2020-12-31 | CN¥2.63 Billion ≈ $384.64 Million |
-25.75% |
| 2019-12-31 | CN¥3.54 Billion ≈ $518.01 Million |
-18.30% |
| 2018-12-31 | CN¥4.33 Billion ≈ $634.08 Million |
+3.07% |
| 2017-12-31 | CN¥4.20 Billion ≈ $615.20 Million |
+146.09% |
| 2016-12-31 | CN¥1.71 Billion ≈ $249.99 Million |
+20.37% |
| 2015-12-31 | CN¥1.42 Billion ≈ $207.69 Million |
-2.10% |
| 2014-12-31 | CN¥1.45 Billion ≈ $212.13 Million |
+2.84% |
| 2013-12-31 | CN¥1.41 Billion ≈ $206.27 Million |
-1.58% |
| 2012-12-31 | CN¥1.43 Billion ≈ $209.58 Million |
+1.67% |
| 2011-12-31 | CN¥1.41 Billion ≈ $206.15 Million |
+4.34% |
| 2010-12-31 | CN¥1.35 Billion ≈ $197.57 Million |
+7.06% |
| 2009-12-31 | CN¥1.26 Billion ≈ $184.54 Million |
+5.23% |
| 2008-12-31 | CN¥1.20 Billion ≈ $175.36 Million |
+14.44% |
| 2007-12-31 | CN¥1.05 Billion ≈ $153.24 Million |
+5.41% |
| 2006-12-31 | CN¥993.45 Million ≈ $145.37 Million |
+5.04% |
| 2005-12-31 | CN¥945.80 Million ≈ $138.40 Million |
+6.41% |
| 2004-12-31 | CN¥888.84 Million ≈ $130.06 Million |
+4.40% |
| 2003-12-31 | CN¥851.39 Million ≈ $124.58 Million |
+5.98% |
| 2002-12-31 | CN¥803.33 Million ≈ $117.55 Million |
+68.69% |
| 2001-12-31 | CN¥476.22 Million ≈ $69.69 Million |
+8.21% |
| 2000-12-31 | CN¥440.10 Million ≈ $64.40 Million |
+10.15% |
| 1999-12-31 | CN¥399.54 Million ≈ $58.47 Million |
+417.65% |
| 1998-12-31 | CN¥77.18 Million ≈ $11.29 Million |
+43.34% |
| 1997-12-31 | CN¥53.85 Million ≈ $7.88 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Zhejiang Shenghua Biok Biology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1675.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥194.82 Million | 5.70% |
| Common Stock | CN¥3.06 Billion | 89.57% |
| Other Comprehensive Income | CN¥311.34 Million | 9.12% |
| Total Equity | CN¥3.42 Billion | 100.00% |
Zhejiang Shenghua Biok Biology Co Ltd Competitors by Market Cap
The table below lists competitors of Zhejiang Shenghua Biok Biology Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Flat Glass Group Co. Ltd
SHG:601865
|
$2.58 Billion |
|
MAG Silver Corp
TO:MAG
|
$2.58 Billion |
|
Koninklijke BAM Groep NV
AS:BAMNB
|
$2.58 Billion |
|
StoneCo Ltd
NASDAQ:STNE
|
$2.58 Billion |
|
XL Axiata Tbk PT
JK:EXCL
|
$2.58 Billion |
|
Genting Malaysia Bhd
KLSE:4715
|
$2.58 Billion |
|
CECEP Solar Energy Co Ltd
SHE:000591
|
$2.57 Billion |
|
Ultragenyx
NASDAQ:RARE
|
$2.57 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Zhejiang Shenghua Biok Biology Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,259,189,338 to 3,415,285,811, a change of 156,096,473 (4.8%).
- Net income of 189,453,476 contributed positively to equity growth.
- Dividend payments of 13,284,298 reduced retained earnings.
- Other comprehensive income increased equity by 35,918,017.
- Other factors decreased equity by 55,990,722.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥189.45 Million | +5.55% |
| Dividends Paid | CN¥13.28 Million | -0.39% |
| Other Comprehensive Income | CN¥35.92 Million | +1.05% |
| Other Changes | CN¥-55.99 Million | -1.64% |
| Total Change | CN¥- | 4.79% |
Book Value vs Market Value Analysis
This analysis compares Zhejiang Shenghua Biok Biology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.47x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 137.54x to 5.47x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1997-12-31 | CN¥0.04 | CN¥5.92 | x |
| 1998-12-31 | CN¥0.06 | CN¥5.92 | x |
| 1999-12-31 | CN¥0.32 | CN¥5.92 | x |
| 2000-12-31 | CN¥0.35 | CN¥5.92 | x |
| 2001-12-31 | CN¥0.38 | CN¥5.92 | x |
| 2002-12-31 | CN¥0.62 | CN¥5.92 | x |
| 2003-12-31 | CN¥0.66 | CN¥5.92 | x |
| 2004-12-31 | CN¥0.68 | CN¥5.92 | x |
| 2005-12-31 | CN¥0.73 | CN¥5.92 | x |
| 2006-12-31 | CN¥0.76 | CN¥5.92 | x |
| 2007-12-31 | CN¥0.80 | CN¥5.92 | x |
| 2008-12-31 | CN¥0.88 | CN¥5.92 | x |
| 2009-12-31 | CN¥0.94 | CN¥5.92 | x |
| 2010-12-31 | CN¥1.02 | CN¥5.92 | x |
| 2011-12-31 | CN¥1.06 | CN¥5.92 | x |
| 2012-12-31 | CN¥1.03 | CN¥5.92 | x |
| 2013-12-31 | CN¥1.11 | CN¥5.92 | x |
| 2014-12-31 | CN¥0.76 | CN¥5.92 | x |
| 2015-12-31 | CN¥0.72 | CN¥5.92 | x |
| 2016-12-31 | CN¥0.83 | CN¥5.92 | x |
| 2017-12-31 | CN¥1.45 | CN¥5.92 | x |
| 2018-12-31 | CN¥1.53 | CN¥5.92 | x |
| 2019-12-31 | CN¥1.13 | CN¥5.92 | x |
| 2020-12-31 | CN¥0.84 | CN¥5.92 | x |
| 2021-12-31 | CN¥0.90 | CN¥5.92 | x |
| 2022-12-31 | CN¥1.05 | CN¥5.92 | x |
| 2023-12-31 | CN¥1.18 | CN¥5.92 | x |
| 2024-12-31 | CN¥1.08 | CN¥5.92 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Zhejiang Shenghua Biok Biology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.55%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.20%
- • Asset Turnover: 0.30x
- • Equity Multiplier: 1.32x
- Recent ROE (5.55%) is below the historical average (7.94%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1997 | 25.75% | 23.13% | 0.44x | 2.54x | CN¥8.48 Million |
| 1998 | 46.10% | 30.82% | 0.72x | 2.09x | CN¥27.86 Million |
| 1999 | 8.59% | 29.48% | 0.27x | 1.09x | CN¥-5.64 Million |
| 2000 | 13.14% | 28.26% | 0.37x | 1.25x | CN¥13.81 Million |
| 2001 | 14.67% | 18.59% | 0.59x | 1.35x | CN¥22.19 Million |
| 2002 | 6.50% | 13.03% | 0.39x | 1.28x | CN¥-27.10 Million |
| 2003 | 6.06% | 8.30% | 0.54x | 1.35x | CN¥-32.57 Million |
| 2004 | 7.06% | 5.97% | 0.76x | 1.56x | CN¥-25.06 Million |
| 2005 | 8.11% | 5.03% | 0.85x | 1.89x | CN¥-17.14 Million |
| 2006 | 7.10% | 4.22% | 0.90x | 1.87x | CN¥-27.64 Million |
| 2007 | 7.86% | 3.89% | 0.99x | 2.03x | CN¥-21.52 Million |
| 2008 | 11.58% | 4.66% | 1.29x | 1.92x | CN¥17.36 Million |
| 2009 | 12.08% | 9.39% | 0.72x | 1.78x | CN¥24.49 Million |
| 2010 | 10.76% | 7.80% | 0.79x | 1.75x | CN¥9.71 Million |
| 2011 | 7.28% | 5.41% | 0.76x | 1.76x | CN¥-35.65 Million |
| 2012 | 2.52% | 2.05% | 0.75x | 1.65x | CN¥-100.70 Million |
| 2013 | 2.05% | 1.73% | 0.69x | 1.72x | CN¥-107.74 Million |
| 2014 | 5.82% | 6.17% | 0.58x | 1.64x | CN¥-59.66 Million |
| 2015 | 9.93% | 13.85% | 0.45x | 1.59x | CN¥-1.03 Million |
| 2016 | 13.85% | 45.94% | 0.15x | 1.98x | CN¥65.55 Million |
| 2017 | 6.21% | 19.83% | 0.24x | 1.30x | CN¥-159.23 Million |
| 2018 | 3.27% | 14.43% | 0.19x | 1.17x | CN¥-292.02 Million |
| 2019 | -18.50% | -81.45% | 0.19x | 1.17x | CN¥-1.01 Billion |
| 2020 | -35.80% | -169.58% | 0.18x | 1.16x | CN¥-1.21 Billion |
| 2021 | 14.10% | 55.05% | 0.23x | 1.11x | CN¥109.08 Million |
| 2022 | 15.62% | 80.13% | 0.18x | 1.07x | CN¥173.64 Million |
| 2023 | 5.09% | 25.58% | 0.15x | 1.32x | CN¥-160.16 Million |
| 2024 | 5.55% | 14.20% | 0.30x | 1.32x | CN¥-152.08 Million |
Industry Comparison
This section compares Zhejiang Shenghua Biok Biology Co Ltd's net assets metrics with peer companies in the Conglomerates industry.
Industry Context
- Industry: Conglomerates
- Average net assets among peers: $1,521,959,146
- Average return on equity (ROE) among peers: 4.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Zhejiang Shenghua Biok Biology Co Ltd (600226) | CN¥3.61 Billion | 25.75% | 0.34x | $2.58 Billion |
| China Baoan Group Co Ltd (000009) | $433.69 Million | 18.48% | 0.53x | $2.33 Billion |
| Yunding Technology Co Ltd (000409) | $375.17 Million | -5.69% | 0.05x | $818.20 Million |
| Create Technology & Science Co Ltd (000551) | $2.40 Billion | 8.20% | 0.94x | $912.89 Million |
| Sundiro Holding Co Ltd (000571) | $2.89 Billion | 0.74% | 0.79x | $699.91 Million |
| Guangdong Ganhua Science & Industry Co Ltd (000576) | $477.56 Million | 13.59% | 0.64x | $398.50 Million |
| Macrolink Real Estate Co Ltd (000620) | $3.06 Billion | 19.53% | 2.48x | $2.43 Billion |
| Tianjin Economic-technological Development Area Co Ltd (000652) | $3.45 Billion | 7.18% | 5.80x | $740.62 Million |
| CHTC Helon Co Ltd (000677) | $643.13 Million | 0.70% | 0.31x | $194.70 Million |
| Gansu Yatai Industrial Development Co Ltd (000691) | $403.37 Million | -20.61% | 0.46x | $684.73 Million |
| Hunan Fazhan Industrial Co Ltd (000722) | $1.09 Billion | 3.07% | 0.80x | $1.20 Billion |
About Zhejiang Shenghua Biok Biology Co Ltd
Zhejiang Hengtong Holding Co.,Ltd. develops, produces, and sells biological pesticides, veterinary drugs, and animal feed additive products in China and Internationally. The company offers electronic and lithium battery copper foil for use in integrated circuit boards, lithium battery electrodes, and other products, as well as amino acid products. It also engages in the cogeneration of heat and p… Read more